Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.
Introduction The management of active patients with symptomatic knee osteoarthritis (KnOA) who are too young for total knee arthroplasty poses a specific challenge to clinicians. Research studies show ...
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical ...
Gunda Georg and Narshimulu Cheryala, who directed much of the lab work to develop YCT-529 Around the world, roughly 121 million unintended pregnancies occurred each year between 2015 and 2019. Of ...
Produced by researchers from the World Bank’s Development Research Group and the Office of the Chief Economist for the Prosperity Vertical, this Policy Research Working Paper by Arthur Mendes and ...
Forbes contributors publish independent expert analyses and insights. Serenity Gibbons is a business consultant who covers entrepreneurs. Across industries, businesses today are more automated and ...
Children grow in height through the activity of growth plates—thin layers of cartilage located at the ends of long bones. These structures contain specialized stem cells that generate new chondrocytes ...
Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results